Express Scripts

Most Recent

  • uploads///Express
    Company & Industry Overviews

    Express Scripts Holding Stock Has Risen 36% in 2018

    On November 29, Express Scripts Holding’s stock price closed at $101.22, which is ~5% growth from the close of $96.81 on November 23.

    By Daniel Collins
  • uploads///GOAT
    Consumer

    How to Invest in Global Wide Moat Stocks

    The Morningstar Global Wide Moat Focus Index has global exposure, unlike the Morningstar International Moat Index (MOTI).

    By VanEck
  • uploads///family _
    Company & Industry Overviews

    UNH’s Stock Price Performance in June

    On June 28, UnitedHealth Group (UNH) ended the trading day at $244.90, ~4.6% lower than its 52-week low of $183.86 reached on July 18, 2017.

    By Sarah Collins
  • uploads///trump tower _
    Consumer

    Drugstore Stocks Tumble ahead of Trump’s New Drug Policy

    The stocks of top drugstore chains CVS Health (CVS) and Walgreens Boots Alliance (WBA) were down yesterday amid ongoing tensions regarding a policy change in US drug pricing.

    By Sonya Bells
  • uploads///BUSINESS POSITIONING
    Earnings Report

    How Is UNH’s Optum Business Positioned in the Industry?

    UnitedHealth Group is, by revenue, the largest healthcare company in the world.

    By Sarah Collins
  • uploads///virus _
    Company & Industry Overviews

    Analyst Ratings for Nektar Therapeutics and Peers in March 2018

    Of the nine analysts covering Nektar Therapeutics in March 2018, four of them have given the stock a “strong buy” rating.

    By Kenneth Smith
  • uploads///LHC
    Company & Industry Overviews

    What’s LHC Group’s Business Strategy?

    In 2018, LHC Group is expected to report revenue of $1.2 billion. What about its peers?

    By Kenneth Smith
  • uploads///hospice _
    Company & Industry Overviews

    What Analysts Recommend for Civitas Solutions in March 2018

    Of the four analysts covering Civitas Solutions, two analysts have given the stock a “strong buy” rating, and two analysts have given it a “buy” rating.

    By Kenneth Smith
  • uploads///hands _
    Healthcare

    Cigna Expects Acquisition of Express Scripts by End of 2018

    On March 7, 2018, Cigna (CI) announced that it has entered into a definitive agreement to acquire Express Scripts (ESRX) for $67 billion.

    By Margaret Patrick
  • uploads///ABC
    Company & Industry Overviews

    Analyzing AmerisourceBergen’s Recent Acquisitions

    In December 2017, AmerisourceBergen (ABC) acquired Northeast Supply Company, or NEVSCO, for a consideration of $70 million.

    By Kenneth Smith
  • uploads///doctors office checkup medical
    Company & Industry Overviews

    Analysts’ Ratings for AmerisourceBergen in March 2018

    Four analysts gave AmerisourceBergen stock a “strong buy” rating, seven analysts gave it a “buy” rating, and seven analysts gave it a “hold” rating.

    By Kenneth Smith
  • uploads///REV EPS GROWTH ESRX
    Miscellaneous

    Express Scripts: How Its Performance Contributed to Its Valuation

    Express Scripts’ (ESRX) revenue fell 1% in both 2016 and the first nine months of 2017.

    By Amanda Lawrence
  • uploads///NET SALES EPS GROWTH MYL
    Consumer

    Mylan: How Its Performance Contributed to Its Valuation

    In this final series of our three-part series, we’ll be looking at the last seven stocks among the top 18 cheap stocks in the S&P 500 for 2018.

    By Amanda Lawrence
  • uploads///a
    Company & Industry Overviews

    Walgreens versus CVS: Discussing PBM Strategies

    In August 2016, Walgreens announced a long-term strategic alliance with Prime Therapeutics, America’s fourth-largest PBM.

    By Sonya Bells
  • uploads///
    Consumer

    Leerink Partners Convinced about Amazon’s Entry in the Pharma Space

    Analysts Ana Gupte of Leerink Partners said in a recent client note that Amazon might enter the drug distribution market within the next two years.

    By Sonya Bells
  • uploads///Graph
    Company & Industry Overviews

    Patient Recovery Acquisition May Boost Cardinal Health’s Revenues

    On July 30, 2017, Cardinal Health (CAH) completed the acquisition of Medtronic’s patient recovery business for an all-cash consideration worth $6.1 billion.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Cardinal Health’s Medical Segment: Key Growth Driver?

    In fiscal 2017, Cardinal Health’s (CAH) Medical segment reported robust demand in areas such as surgical kitting, lab services, post acute, and medical services.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Robust Growth Expected for Cardinal Health’s Specialty Solutions

    Cardinal Health’s (CAH) Specialty Solutions segment provides two types of services: upstream to pharmaceutical and biopharmaceutical manufacturers and downstream to healthcare providers.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Cardinal Health: Stable Net Profit Margins in Fiscal 2018?

    Wall Street analysts have projected Cardinal Health’s fiscal 2018 net profit margins to be 1.0%, which will be similar to what the company reported in fiscal 2017.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Cardinal Health Expected to Report Modest Revenue Growth

    For fiscal 2018, Cardinal Health (CAH) has projected mid-single-digit revenue growth on a YoY basis, partially driven by the company’s high customer retention rates.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Eosinophilic Esophagitis: Major Market Opportunity for Dupixent?

    Regeneron (REGN) has obtained positive results from its Phase 2 proof-of-concept study evaluating Dupixent in eosinophilic esophagitis.

    By Margaret Patrick
  • uploads///part
    Company & Industry Overviews

    How 3M Company’s Products Look After Your Health

    Revenues from 3M Company’s (MMM) Healthcare segment rose from 16.7% ($5 billion) of total annual revenue in 2011 to 17.5% ($5.4 billion) in 2015.

    By Shannon Black
  • uploads///part
    Company & Industry Overviews

    Why 3M Sees an Opportunity in Tier B Chinese Hospitals

    20% of 3M Company’s (MMM) Healthcare sales are derived from developing economies, which have been growing organically since 2012.

    By Shannon Black
  • Company & Industry Overviews

    PLGAX Slips in 2016 after a Superlative 2015

    PLGAX had a great year in 2015, as its risk-adjusted returns, the consistency of returns, and alpha ranked it as the second-best fund in our peer group.

    By David Ashworth
  • uploads///Graph
    Earnings Report

    Anthem Expects to Generate Substantial Savings from Pharmaceutical Pricing in 2016

    Anthem plans to negotiate pharmaceutical pricing with Express Scripts in an effort to improve affordability, secure more members, and enroll new customers.

    By Margaret Patrick
  • uploads///Graph Part  Nov
    Company & Industry Overviews

    Express Scripts Trades Above Its 100-Day Moving Average

    Express Scripts Holdings rose 0.4%. The company was in the news on November 10 when it announced that it would remove Linden Care Pharmacy from its network.

    By Peter Neil
  • uploads///Part
    Earnings Report

    Earnings Analysis: CVS Health’s Performance in 2Q15

    CVS Health declared its 2Q15 results on August 4, beating consensus Wall Street analyst estimates for the fifth straight quarter. The company’s results were upbeat, with sales rising 7.4% year-over-year to $37.2 billion.

    By Phalguni Soni
  • uploads///Part
    Earnings Report

    Drivers That Impact CVS’s Pharmacy Services Segment

    CVS Health (CVS) is projecting 2Q15 revenue growth between 11.25% and 12.5% for its Pharmacy Services, which provides pharmacy benefit management (or PBM) services.

    By Phalguni Soni
  • uploads///Graph
    Earnings Report

    UnitedHealth Group’s Optum Posts Healthy 1Q15 Operating Earnings

    The Optum segment offers pharmacy, quality management, and health technology services. Operating earnings grew by 14% year-over-year to $742 million.

    By Margaret Patrick
  • Fund Managers

    An overview of Berkshire Hathaway’s 3Q positions

    The size of Berkshire Hathaway’s US long portfolio increased slightly from $107.5 billion in 2Q14 to $107.7 billion in 3Q14.

    By Samantha Nielson
  • uploads///ESRX
    Healthcare

    Maverick Capital sells its stake in Express Scripts Holding

    Maverick Capital exited a 3.5% position in Express Scripts Holding Co. (ESRX). The position was initiated in 3Q 2013.

    By Samantha Nielson
  • uploads///CTRX
    Consumer

    Lee Ainslie’s Maverick Capital buys a stake in Catamaran Corp.

    Pharmacy benefit manager Catamaran Corp. (CTRX) is a new position initiated by Maverick that accounts for 2.46% of the fund’s fourth quarter portfolio.

    By Samantha Nielson
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.